Cite
HARVARD Citation
Dailey, G. et al. (2018). Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL. Endocrinology, diabetes & metabolism. 1 (4), p. n/a. [Online].